AMSBIO has expanded its range of primary human cancer cells sourced from a wide variety of tissue types that allow the study of cancer in a more in vivo like fashion.
The deadline for compliance with the EU Medical Device Regulations is looming. On the 25th of May 2017, new EU regulations for medical devices and in vitro diagnostic medical devices entered into force, giving medical device companies a 3 / 5 - year transition period to achieve compliance. Whilst the MDR has been delayed as a result of the COVID-19 pandemic, by May 2021 medical devices must adhere to the updated regulations, transitioning from the Medical Device Directive (MDD) to the Medical Device Regulations (MDR).
UPPSALA, Sweden, February 2, 2021 - LINK Medical, the Northern European clinical research organization (CRO), and the Swedish women’s health company Gedea Biotech announced today that it has enrolled the first patient in the NEFERTITI clinical study of its lead product, pHyph, a vaginal tablet for topical treatment of bacterial vaginosis (BV). The randomized double-blind placebo-controlled study is designed to confirm safety and efficacy of pHyph and is coordinated by Nottingham University NHS Hospitals Trust in the UK and LINK Medical.
27 January 2021
tranScrip is delighted to announce a significant minority investment from Palatine Private Equity Impact Fund, which complements the existing investment of tranScrip’s own Partners. The deal is a landmark for tranScrip, underpinning its growth as a leading specialist service provider.
ProductLife Group already has a fairly long success story: born in 1993, focusing on RA since 2006 and after becoming a Group, through acquisitions from 2012 onwards, PLG was reborn once again after LBO by 21Invest.
All along, it has kept the ProductLife vision of contributing to improve human health, with its main competences, regulatory affairs, safety & vigilances and quality compliance.
In 2020, ProductLife Group has reached a first step of notoriety as PLG, a European leading service provider for top pharmaceutical companies.
Saffron Walden, UK, 21st January 2021 / Domainex Ltd., a leading provider of integrated drug discovery services, is pleased to welcome David Cronk, CBiol, MRSB, to the team as its new Chief of Staff. The Company has also promoted long standing team member and previous Head of Chemistry, Dr Ray Boffey, to Executive Director of Medicines Research. Following a successful period of growth and expansion of its research team, both David and Ray bring a wealth of drug discovery experience and will further support Domainex’s ongoing growth plans.
The cfPure® Cell Free DNA Extraction Kit from AMSBIO is a magnetic bead-based DNA extraction kit designed to isolate circulating cell free DNA (cfDNA) from human plasma or serum samples.
Research Triangle Park, NC, USA and Cambridge, UK, 20 January 2021 – Inivata, a leader in liquid biopsy, today announces that the first patients have been tested using InVisionFirst®-Lung as part of the Phase II ALKALINE trial sponsored by the European Organisation for Research and Treatment of Cancer (EORTC). As part of the study Inivata’s InVisionFirst-Lung liquid biopsy will be used to test and monitor ALK positive non-small cell lung cancer (NSCLC) patients initiating treatment with lorlatinib, Pfizer Inc.’s third generation ALK inhibitor therapy.